Tessa Altair Morris

Tessa Altair Morris

Auto-generated profile, based on publicly available information

Tessa Altair Morris

Edwards Lifesciences Foundation Cardiovascular Innovation & Research Center and Center for Complex Biological Systems and The NSF-Simons Center for Multiscale Cell Fate Research, University of California

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2020 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
TMTessa Altair Morris
Tessa Altair Morris
JNJasmine Naik
Jasmine Naik
KFKirby Sinclair Fibben
Kirby Sinclair Fibben
XKXiangduo Kong
Xiangduo Kong
TKTohru Kiyono
Tohru Kiyono
AGAnna Grosberg
Anna Grosberg
As sarcomeres produce the force necessary for contraction, assessment of sarcomere order is paramount in evaluation of cardiac and skeletal myocytes. The uniaxial force produced by sarcomeres is ideally perpendicular to their z-lines, which couple parallel myofibrils and give cardiac and skeletal myocytes their distinct striated appearance. Accordingly, sarcomere structure is often evaluated by staining for z-line proteins such as α-actinin. However, due to limitations of current analysis methods, which require manual or semi-manual handling of images, the mechanism by which sarcomere and by extension z-line architecture can impact contraction and which characteristics of z-line architecture should be used to assess striated myocytes has not been fully explored. Challenges such as isolating z-lines from regions of off-target staining that occur along immature stress fibers and cell boundaries and choosing metrics to summarize overall z-line architecture have gone largely unaddressed in previous work. While an expert can qualitatively appraise tissues, these challenges leave researchers without robust, repeatable tools to assess z-line architecture across different labs and experiments. Additionally, the criteria used by experts to evaluate sarcomeric architecture have not been well-defined. We address these challenges by providing metrics that summarize different aspects of z-line architecture that correspond to expert tissue quality assessment and demonstrate their efficacy through an examination of engineered tissues and single cells. In doing so, we have elucidated a mechanism by which highly elongated cardiomyocytes become inefficient at producing force. Unlike previous manual or semi-manual methods, characterization of z-line architecture using the metrics discussed and implemented in this work can quantitatively evaluate engineered tissues and contribute to a robust understanding of the development and mechanics of striated muscles. Structural evaluation of sarcomeres is fundamental to the study of striated muscle. However, due to limitations of current analysis methods, the mechanisms by which sarcomere order can impact contraction and the characteristics of sarcomere architecture that should be used to assess striated myocytes have not been fully explored. Furthermore, it is not clear what aspects of sarcomere architecture are considered by the experts when qualitatively evaluating striated muscle tissues. Therefore, we developed a computational structural assay in MATLAB, ZlineDetection, to evaluate sarcomere architecture by both extracting sarcomeric z-lines from images and providing metrics that encapsulate different aspects of z-line architecture that an expert would evaluate when judging the quality of the tissue. The sarcomere structure of both patient-specific skeletal muscle and rat cardiomyocytes were evaluated with differences among engineered cells and tissues quantified using novel and established metrics. As a result, a mechanism by which highly elongated cardiomyocytes become inefficient at producing force was elucidated. ZlineDetection identifies and quantifies the characteristics used by experts for evaluation and thus it will lead to more rigorous differentiation methods and tissue comparison across labs and contribute a robust understanding of how structure affects mechanical function.

29 March 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
AHAnicca Harriot
Anicca Harriot
TATessa Altair-Morris
Tessa Altair-Morris
CVCamilo Venegas
Camilo Venegas
JKJacob Kallenbach
Jacob Kallenbach
KPKaylie Pinto
Kaylie Pinto
CWChristopher W. Ward
Christopher W. Ward
In Duchenne muscular dystrophy (DMD), alterations in the myofibrillar structure of skeletal muscle fibers that impair contractile function and increase injury susceptibility arise as a consequence of dystrophic pathology. In murine DMD ( mdx ), myofibrillar alterations are abundant in advanced pathology (>4 months), an age where we formerly established the densification of microtubules (MTs) post-translationally modified by detyrosination (deTyr-MTs) as a negative disease modifier. Given the essential role of MTs in myofibrillar growth, maintenance, and repair, we examined the increased abundance of deTyr-MTs as a potential mechanism for these myofibrillar alterations. Here we find increased levels of deTyr-MTs as an early event in dystrophic pathology (4 weeks) with no evidence of myofibrillar alterations. At 16 weeks, we show the level of deTyr-MTs is significantly increased and co-localized to areas of myofibrillar malformation. Profiling the enzyme complexes responsible for deTyr-tubulin, we identify vasohibin 2 (VASH2) and small vasohibin binding protein (SVBP) significantly elevated in the mdx muscle at 4 wks. We then use the genetic increase in VASH2/SVBP expression in 4 wk wild-type mice and find densified deTyr-MTs that co-segregate with myofibrillar malformations similar to those in the 16 wk mdx . Given that no changes were identified in fibers expressing EGFP as a control, we conclude that disease dependent densification of deTyr-MTs underscores the altered myofibrillar structure in dystrophic skeletal muscle fibers.